Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.58 |
| ▸ | GJB2 | P29033 | 1/20 | 0.44 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.43 |
| ▸ | SLC5A2 | P31639 | 2/20 | 0.40 |
| ▸ | PDE2A | O00408 | 1/20 | 0.40 |
| ▸ | HRAS | P01112 | 1/20 | 0.40 |
| ▸ | HOGA1 | Q86XE5 | 1/20 | 0.39 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7599764 | 1.00 | SLC6A2 (0.58) | SLC6A2GJB2PDE4DTSHRHSPA5 | |
| SCHEMBL18425232 | 0.91 | SLC6A2 (0.51) | SLC6A2GJB2PDE4DTSHRHSPA5 | |
| SCHEMBL29546413 | 0.89 | SLC6A2 (0.49) | SLC6A2GJB2PDE4DTSHRHSPA5 | |
| SCHEMBL11112700 | 0.86 | SLC6A2 (0.46) | SLC6A2GJB2PDE4DTSHRHSPA5 | |
| SCHEMBL7642040 | 0.86 | SLC6A2 (0.49) | SLC6A2GJB2PDE4DTSHRHSPA5 | |
| SCHEMBL9371105 | 0.86 | SLC6A2 (0.48) | SLC6A2GJB2PDE4DTSHRHSPA5 | |
| SCHEMBL9371098 | 0.86 | SLC6A2 (0.48) | SLC6A2GJB2PDE4DTSHRHSPA5 | |
| SCHEMBL7751627 | 0.85 | GJB2 (0.48) | SLC6A2GJB2PDE4D | |
| SCHEMBL7152910 | 0.85 | GJB2 (0.48) | SLC6A2GJB2PDE4D | |
| SCHEMBL7751632 | 0.85 | GJB2 (0.48) | SLC6A2GJB2PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023194941-A1 | LARGE SCALE PRODUCTION OF N-ACETYLLACTOSAMINE DERIVATIVES | KODE BIOTECH LIMITED (NZ) | 2023-10-12 | — | — | WO | disclosed |
| CN-103649033-A | Family of aryl, heteroaryl, O-aryl and O-heteroaryl carbocyclic sugars | TFCHEM (FR) | 2014-03-19 | — | — | CN | disclosed |
| CN-1241925-C | New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them | ADIR (FR) | 2006-02-15 | — | — | CN | disclosed |
| CN-1496989-A | New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them | ɪά��ʵ���� | 2004-05-19 | — | — | CN | disclosed |
| EP-1261614-A2 | METHOD FOR THE PRODUCTION OF PERBENZYLATED 1-O GLYCOSIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-12-04 | — | — | EP | disclosed |
| WO-2001068659-A2 | METHOD FOR THE PRODUCTION OF PERBENZYLATED 1-O GLYCOSIDES | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-09-20 | — | — | WO | disclosed |
| US-5491152-A | Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-02-13 | — | — | US | disclosed |